Author:
Shinaoka Akira,Kamiyama Kazuyo,Yamada Kiyoshi,Kimata Yoshihiro
Abstract
AbstractMost protocols for lymphatic imaging of the lower limb conventionally inject tracer materials only into the interdigital space; however, recent studies indicate that there are four independent lymphatic vessel groups (anteromedial, anterolateral, posteromedial, and posterolateral) in the lower limb. Thus, three additional injection sites are needed for lymphatic imaging of the entire lower limb. We aimed to validate a multiple injection designed protocol and demonstrate its clinical benefits. Overall, 206 lower limbs undergoing indocyanine green fluorescent lymphography with the new injection protocol were registered retrospectively. To assess the influence of predictor variables on the degree of severity, multivariable logistic regression models were used with individual known risk factors. Using a generalized linear model, the area under the curve (AUC) of the conventional clinical model, comprising known severity risk factors, was compared with that of the modified model that included defects in the posterolateral and posteromedial groups. Multivariable logistic regression models showed a significant difference for the posteromedial and posterolateral groups. The AUC of the modified model was significantly improved compared to that of the conventional clinical model. Finding defects in the posteromedial and posterolateral groups is a significant criterion for judging lymphedema severity and introducing a new lymphedema severity classification.
Funder
Japan Society for the Promotion of Science
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Mansel, R. E. et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial. J. Natl. Cancer Inst. 98(9), 599–609 (2006).
2. Leidenius, M., Leivonen, M., Vironen, J. & von Smitten, K. The consequences of long-time arm morbidity in node-negative breast cancer patients with sentinel node biopsy or axillary clearance. J. Surg. Oncol. 92(1), 23–31 (2005).
3. Swenson, K. K. et al. Comparison of side effects between sentinel lymph node and axillary lymph node dissection for breast cancer. Ann. Surg. Oncol. 9(8), 745–753 (2002).
4. Biglia, N., Zanfagnin, V., Daniele, A., Robba, E. & Bounous, V. E. Lower body lymphedema in patients with gynecologic cancer. Anticancer Res. 37(8), 4005–4015 (2017).
5. Watanabe, Y. et al. Development and themes of diagnostic and treatment procedures for secondary leg lymphedema in patients with gynecologic cancers. Healthcare (Basel) 7(3), 101 (2019).
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献